180 related articles for article (PubMed ID: 20335618)
1. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B.
Sauer A; Letscher-Bru V; Speeg-Schatz C; Touboul D; Colin J; Candolfi E; Bourcier T
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3950-3. PubMed ID: 20335618
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.
Martins SA; Combs JC; Noguera G; Camacho W; Wittmann P; Walther R; Cano M; Dick J; Behrens A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3402-8. PubMed ID: 18408193
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
Singh J; Rimek D; Kappe R
Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
[TBL] [Abstract][Full Text] [Related]
5. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
Heller I; Leitner S; Dierich MP; Lass-Flörl C
Int J Antimicrob Agents; 2004 Oct; 24(4):401-4. PubMed ID: 15380269
[TBL] [Abstract][Full Text] [Related]
6. Correlation of proteinase production with amphotericin B resistance in fungi from mycotic keratitis.
Nayak N; Satpathy G; Prasad S; Vajpayee RB; Pandey RM
Ophthalmic Res; 2010; 44(2):113-8. PubMed ID: 20516724
[TBL] [Abstract][Full Text] [Related]
7. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.
Arboleda A; Miller D; Cabot F; Taneja M; Aguilar MC; Alawa K; Amescua G; Yoo SH; Parel JM
Am J Ophthalmol; 2014 Jul; 158(1):64-70.e2. PubMed ID: 24792103
[TBL] [Abstract][Full Text] [Related]
8. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
Chryssanthou E; Sjölin J
J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
10. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of amphotericin-B pimaricin and gentian violet on ocular fungi.
Lavingia B; Dave S
Indian J Ophthalmol; 1986; 34():73-7. PubMed ID: 3155339
[No Abstract] [Full Text] [Related]
13. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
Xie L; Zhai H; Zhao J; Sun S; Shi W; Dong X
Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis.
Yilmaz S; Ture M; Maden A
Cornea; 2007 May; 26(4):398-402. PubMed ID: 17457185
[TBL] [Abstract][Full Text] [Related]
15. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Amphotericin B Against Fusarium and Aspergillus in Corneal Storage Medium.
Duncan K; Parker J; Hoover C; Lindquist TD; Jeng BH
Eye Contact Lens; 2018 Nov; 44(6):390-392. PubMed ID: 30376531
[TBL] [Abstract][Full Text] [Related]
17. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Krishnan S; Manavathu EK; Chandrasekar PH
J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
[TBL] [Abstract][Full Text] [Related]
19. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
Yang C; Gong W; Lu J; Zhu X; Qi Q
J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
[TBL] [Abstract][Full Text] [Related]
20. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
